Viemed Healthcare, Inc. (VMD)

Viemed Healthcare Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	240.88	224.26	183.01	138.83	117.06	131.31
Revenue Growth (YoY)	17.11%	22.54%	31.82%	18.60%	-10.85%	63.61%
Cost of Revenue	100.37	91.05	70.23	54.15	43.65	51.2
Gross Profit	140.52	133.2	112.78	84.68	73.41	80.11
Selling, General & Admin	111.95	105.85	87.35	68.16	54.89	52.83
Research & Development	3.2	3.07	2.78	2.7	2.11	1.08
Other Operating Expenses	-0.51	-0.73	-0.1	-0.79	-0.12	-0.45
Operating Expenses	123.92	115.95	97.27	76.28	62.88	59.16
Operating Income	16.6	17.25	15.51	8.4	10.53	20.95
Interest Expense	-0.68	-0.78	-0.42	-0.2	-0.32	-0.51
Interest & Investment Income	-	-	0.49	0.94	-	-
Earnings From Equity Investments	1.05	-	-	-	1.24	0.09
EBT Excluding Unusual Items	16.97	16.47	15.57	9.14	11.45	20.54
Merger & Restructuring Charges	-0.16	-0.35	-0.54	-	-	-
Gain (Loss) on Sale of Investments	-0.95	-0.95	-	-	-	-
Gain (Loss) on Sale of Assets	4.58	1.91	-0.65	-0.35	-0.45	2.33
Other Unusual Items	-	-0.9	-	0.2	1.5	3.5
Pretax Income	20.43	16.17	14.39	8.99	12.5	26.36
Income Tax Expense	6.14	4.76	4.15	2.77	3.38	-5.17
Earnings From Continuing Operations	14.29	11.41	10.24	6.22	9.13	31.53
Minority Interest in Earnings	-0.31	-0.14	-	-	-	-
Net Income	13.98	11.27	10.24	6.22	9.13	31.53
Net Income to Common	13.98	11.27	10.24	6.22	9.13	31.53
Net Income Growth	47.63%	9.98%	64.63%	-31.82%	-71.06%	269.85%
Shares Outstanding (Basic)	39	39	38	39	39	39
Shares Outstanding (Diluted)	41	41	40	40	41	41
Shares Change (YoY)	2.48%	1.05%	1.44%	-2.15%	0.38%	1.96%
EPS (Basic)	0.36	0.29	0.27	0.16	0.23	0.81
EPS (Diluted)	0.34	0.28	0.25	0.16	0.22	0.78
EPS Growth	47.14%	12.00%	56.25%	-27.27%	-71.80%	271.43%
Free Cash Flow	-3.6	1.32	19.12	4.85	2.75	22.07
Free Cash Flow Per Share	-0.09	0.03	0.47	0.12	0.07	0.54
Gross Margin	58.34%	59.40%	61.63%	60.99%	62.71%	61.01%
Operating Margin	6.89%	7.69%	8.48%	6.05%	8.99%	15.96%
Profit Margin	5.80%	5.02%	5.60%	4.48%	7.80%	24.01%
Free Cash Flow Margin	-1.50%	0.59%	10.45%	3.49%	2.35%	16.80%
EBITDA	42.88	42.62	37.38	24.03	21.84	30.54
EBITDA Margin	17.80%	19.00%	20.42%	17.31%	18.66%	23.25%
D&A For EBITDA	26.28	25.37	21.86	15.63	11.31	9.58
EBIT	16.6	17.25	15.51	8.4	10.53	20.95
EBIT Margin	6.89%	7.69%	8.48%	6.05%	8.99%	15.96%
Effective Tax Rate	30.05%	29.44%	28.82%	30.79%	27.01%	-

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q